Isoray Inc

IsoRay, Inc. is a medical technology company headquartered in Richland, Washington, specializing in the development, manufacturing, and commercialization of isotope-based products and devices for cancer treatment. The company is the sole producer of Cesium-131 brachytherapy seeds, a patented radioactive seed technology used in the internal radiatio... n treatment of multiple cancer types, including prostate, brain, lung, head and neck, gynecological, and colorectal cancers. IsoRay's CS-1 Cesium-131 seeds are FDA-cleared and sold to hospitals, surgical facilities, and physician practices across the United States. The company was founded in 1998 and built its platform around a proprietary process for separating and purifying Cesium-131, offering a clinically differentiated alternative to traditional Iodine-125 and Palladium-103 brachytherapy options. In March 2023, IsoRay completed a merger with Viewpoint Molecular Targeting and the combined entity was renamed Perspective Therapeutics, IncRead More